Duchenne muscular dystrophy trials in Japan

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

  Where

  Kobe, Kodaira, Tokyo

  Age

  Up to 64 years

  People

  400 worldwide

  Run by

  Sarepta Therapeutics, Inc.

  See details and how to joinNCT05967351 · EU 2023-505043-39-00